These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17125209)

  • 1. The importance of local chemical structure for chemical metabolism by human uridine 5'-diphosphate-glucuronosyltransferase.
    Sorich MJ; McKinnon RA; Miners JO; Smith PA
    J Chem Inf Model; 2006; 46(6):2692-7. PubMed ID: 17125209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple pharmacophores for the investigation of human UDP-glucuronosyltransferase isoform substrate selectivity.
    Sorich MJ; Miners JO; McKinnon RA; Smith PA
    Mol Pharmacol; 2004 Feb; 65(2):301-8. PubMed ID: 14742671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotine glucuronidation and the human UDP-glucuronosyltransferase UGT2B10.
    Kaivosaari S; Toivonen P; Hesse LM; Koskinen M; Court MH; Finel M
    Mol Pharmacol; 2007 Sep; 72(3):761-8. PubMed ID: 17576790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates.
    Fujiwara R; Nakajima M; Yamanaka H; Katoh M; Yokoi T
    Drug Metab Dispos; 2008 Feb; 36(2):361-7. PubMed ID: 17998297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amino terminal domains of human UDP-glucuronosyltransferases (UGT) 2B7 and 2B15 associated with substrate selectivity and autoactivation.
    Lewis BC; Mackenzie PI; Elliot DJ; Burchell B; Bhasker CR; Miners JO
    Biochem Pharmacol; 2007 May; 73(9):1463-73. PubMed ID: 17223084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid prediction of chemical metabolism by human UDP-glucuronosyltransferase isoforms using quantum chemical descriptors derived with the electronegativity equalization method.
    Sorich MJ; McKinnon RA; Miners JO; Winkler DA; Smith PA
    J Med Chem; 2004 Oct; 47(21):5311-7. PubMed ID: 15456275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico insights: chemical and structural characteristics associated with uridine diphosphate-glucuronosyltransferase substrate selectivity.
    Smith PA; Sorich MJ; McKinnon RA; Miners JO
    Clin Exp Pharmacol Physiol; 2003 Nov; 30(11):836-40. PubMed ID: 14678246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoform-selective probe substrates for in vitro studies of human UDP-glucuronosyltransferases.
    Court MH
    Methods Enzymol; 2005; 400():104-16. PubMed ID: 16399346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in the in silico modelling of UDP glucuronosyltransferase substrates.
    Sorich MJ; Smith PA; Miners JO; Mackenzie PI; McKinnon RA
    Curr Drug Metab; 2008 Jan; 9(1):60-9. PubMed ID: 18220572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of linear and nonlinear classification algorithms for the prediction of drug and chemical metabolism by human UDP-glucuronosyltransferase isoforms.
    Sorich MJ; Miners JO; McKinnon RA; Winkler DA; Burden FR; Smith PA
    J Chem Inf Comput Sci; 2003; 43(6):2019-24. PubMed ID: 14632453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eudismic analysis of tricyclic sesquiterpenoid alcohols: lead structures for the design of potent inhibitors of the human UDP-glucuronosyltransferase 2B7.
    Bichlmaier I; Kurkela M; Siiskonen A; Finel M; Yli-Kauhaluoma J
    Bioorg Chem; 2007 Oct; 35(5):386-400. PubMed ID: 17706742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights on membrane topology and structure/function of UDP-glucuronosyltransferases.
    Magdalou J; Fournel-Gigleux S; Ouzzine M
    Drug Metab Rev; 2010 Feb; 42(1):159-66. PubMed ID: 19807219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human UDP-glucuronosyltransferase isoforms involved in bisphenol A glucuronidation.
    Hanioka N; Naito T; Narimatsu S
    Chemosphere; 2008 Dec; 74(1):33-6. PubMed ID: 18990428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of the cofactor-binding domain of the human phase II drug-metabolism enzyme UDP-glucuronosyltransferase 2B7.
    Miley MJ; Zielinska AK; Keenan JE; Bratton SM; Radominska-Pandya A; Redinbo MR
    J Mol Biol; 2007 Jun; 369(2):498-511. PubMed ID: 17442341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of N-terminal domain histidine and proline residues on the substrate selectivities of human UDP-glucuronosyltransferase 1A1, 1A6, 1A9, 2B7, and 2B10.
    Kerdpin O; Mackenzie PI; Bowalgaha K; Finel M; Miners JO
    Drug Metab Dispos; 2009 Sep; 37(9):1948-55. PubMed ID: 19487247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereochemical and steric control of the UDP-glucuronosyltransferase-catalyzed conjugation reaction: a rational approach for the design of inhibitors for the human UGT2B7.
    Bichlmaier I; Finel M; Sippl W; Yli-Kauhaluoma J
    ChemMedChem; 2007 Dec; 2(12):1730-40. PubMed ID: 17943712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carboxyl-glucuronidation of mitiglinide by human UDP-glucuronosyltransferases.
    Yu L; Lu S; Lin Y; Zeng S
    Biochem Pharmacol; 2007 Jun; 73(11):1842-51. PubMed ID: 17359941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The glucuronidation of Delta4-3-Keto C19- and C21-hydroxysteroids by human liver microsomal and recombinant UDP-glucuronosyltransferases (UGTs): 6alpha- and 21-hydroxyprogesterone are selective substrates for UGT2B7.
    Bowalgaha K; Elliot DJ; Mackenzie PI; Knights KM; Miners JO
    Drug Metab Dispos; 2007 Mar; 35(3):363-70. PubMed ID: 17151189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The uridine diphosphate glucuronosyltransferases: quantitative structure-activity relationships for hydroxyl polychlorinated biphenyl substrates.
    Wang D
    Arch Toxicol; 2005 Oct; 79(10):554-60. PubMed ID: 15889236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substrate specificity of the human UDP-glucuronosyltransferase UGT2B4 and UGT2B7. Identification of a critical aromatic amino acid residue at position 33.
    Barre L; Fournel-Gigleux S; Finel M; Netter P; Magdalou J; Ouzzine M
    FEBS J; 2007 Mar; 274(5):1256-64. PubMed ID: 17263731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.